---
layout: talk_reveal3
title: SARS-CoV-2 Variants of Concern
venue: BMGF
event: COVID Epi-Modeling Team Meeting
author: Trevor Bedford
widescreen: true
---

<!-- Outline:

Topics:
- Nextstrain tracking
- Variants of Concern
- Expectations for evolution
  - Seasonal CoV antigenic evolution
	- Comparison to influenza
- Genomic surveillance
-->

<!-- Presentation time of 15 minutes with 5 minutes for questions -->

<section data-background-iframe="/talks/viz/gradient/">
	<h2 class="title">{{ page.title }}</h2>
	<br>&nbsp;<br>
	<p class="title">
	Trevor Bedford (@trvrb)
	<br>
	Associate Professor, Fred Hutchinson Cancer Research Center
	<br>
	{{ page.date | date: "%-d %b %Y" }}
	<br>
	{{ page.event }}
	<br>
	{{ page.venue }}
	<br>&nbsp;<br>
	Slides at: bedford.io/talks
</section>

<section class="left-align">
	<h3>1. Emergence of variants of concern</h3>
	<h3>2. Expectations for antigenic evolution</h3>
</section>

<section data-background="#000000">
	<h1 class="title">Emergence of variants of concern</h1>
</section>

<section>
	<h3>Over 480k SARS-CoV-2 genomes shared to GISAID and evolution tracked in real-time at nextstrain.org</h3>
	<img class="stretch" data-src="/images/talks/ncov_tree_map_2021_01_12_global.png">
	<div class="citation">
		<a href="https://nextstrain.org">nextstrain.org</a>
	</div>
</section>

<!-- <section>
	<h3>SARS-CoV-2 lineages establish globally in February and March</h3>
	<img class="stretch" src="/images/talks/ncov_tree_map_early_pandemic.png">
	<div class="citation">
		<a href="/papers/bedford-ncov-cryptic-transmission/">Bedford et al. 2020. Science.</a>
	</div>
</section>

<section>
	<h3>Limited early mutations like D614G spread globally during initial wave</h3>
	<img class="stretch" src="/images/talks/ncov_d614g_european_introduction.png">
	<div class="citation">
		<a href="https://nextstrain.org">nextstrain.org</a>
	</div>
</section>

<section>
	<h3>Summer and fall variants were confined to regional dominance</h3>
	<img class="stretch" data-src="/images/talks/ncov_a222v_tree_map.jpg">
	<div class="citation">
		<a href="https://www.medrxiv.org/content/10.1101/2020.10.25.20219063v1">Hodcroft et al. 2020. medRxiv.</a>
	</div>
</section> -->

<!-- The S1 subunit contains a receptor-binding domain that recognizes and binds to the
host receptor angiotensin-converting enzyme 2 ACE-2, while the S2 subunit mediates viral
cell membrane fusion by forming a six-helical bundle via the two-heptad repeat domain. -->

<!-- <section>
	<h3>Spike protein is critical for cell invasion by the virus and is the primary target for human immune response</h3>
	<img class="stretch" data-src="/images/talks/sars_cov_2_spike_structure.png">
	<div class="citation">
		<a href="https://science.sciencemag.org/content/367/6483/1260">Wrapp et al. 2020. Science.</a>
	</div>
</section> -->

<section>
	<h3>484K and 501Y repeatedly emerging across the world</h3>
	<img class="stretch" data-src="/images/talks/ncov_variants_484K_501Y_2021_02_05.png">
	<div class="citation">
		<a href="https://nextstrain.org">nextstrain.org</a>
	</div>
</section>

<section>
	<h3>Emergence of 501Y.V1 (B.1.1.7) in the UK</h3>
	<img class="stretch" data-src="/images/talks/ncov_variants_501Y.V1_clock_2021_01_12.png">
	<div class="citation">
		<a href="https://nextstrain.org">nextstrain.org</a>
	</div>
</section>

<section>
	<h3>Emergence of 501Y.V2 (B.1.351) in the South Africa</h3>
	<img class="stretch" data-src="/images/talks/ncov_variants_501Y.V2_clock_2021_01_12.png">
	<div class="citation">
		<a href="https://nextstrain.org">nextstrain.org</a>
	</div>
</section>

<section>
	<h3>Emergence of 501Y.V3 (P.1) in the Brazil</h3>
	<img class="stretch" data-src="/images/talks/ncov_variants_501Y.V3_clock_2021_01_12.png">
	<div class="citation">
		<a href="https://nextstrain.org">nextstrain.org</a>
	</div>
</section>

<section>
	<div class="left" style="float:left; width:54%">
		<h3>Substantial convergent evolution</h3>
	</div>
	<div class="right" style="float:right; width:44%">
		<img data-src="/images/talks/ncov_variants_shared_mutations_2021_02_05.png">
	</div>
	<div class="citation">
		<a href="https://covariants.org">covariants.org</a>
	</div>
</section>

<section class="left-align">
	<h3>
		Three occurences makes a pattern.
		Working hypothesis of rare events occurring during chronic infection,
		driven by natural selection for immune escape.
	</h3>
</section>

<section>
	<h3>Rapid within-host evolution during persistent infection</h3>
	<img class="stretch" data-src="/images/talks/ncov_variants_choi_chronic_tree.png">
	<div class="citation">
		<a href="https://www.nejm.org/doi/full/10.1056/NEJMc2031364">Choi et al. 2020. NEJM.</a>
	</div>
</section>

<section>
	<h3>484K and 501Y observed during this evolution</h3>
	<img class="stretch" data-src="/images/talks/ncov_variants_choi_chronic_alignment.png">
	<div class="citation">
		<a href="https://www.nejm.org/doi/full/10.1056/NEJMc2031364">Choi et al. 2020. NEJM.</a>
	</div>
</section>

<section data-background="#000000">
	<h1 class="title">Expectations for antigenic evolution</h1>
</section>

<section>
	<h3>Up to December, my expectation was evolution as seen in seasonal coronaviruses</h3>
	<img class="stretch" data-src="/images/talks/seasonal_cov_adaptation_accumulation_oc43_elife.png">
	<div class="citation">
		<a href="/papers/kistler-hcov-adaptive-evolution/">Kistler and Bedford. 2021. eLife.</a>
	</div>
</section>

<section>
	<h3>OC43 and 229E show flu B-like rates of adaptive evolution in S1</h3>
	<img class="stretch" data-src="/images/talks/seasonal_cov_adaptation_rate_comparison_elife.jpg">
	<div class="citation">
		<a href="/papers/kistler-hcov-adaptive-evolution/">Kistler and Bedford. 2021. eLife.</a>
	</div>
</section>

<!-- <section>
	<h3>229E shows gradual antigenic drift as measured by neutralization assays</h3>
	<img class="stretch" data-src="/images/talks/seasonal_cov_eguia_antigenic_drift.png">
	<div class="citation">
		<a href="https://www.biorxiv.org/content/10.1101/2020.12.17.423313v1">Eguia et al. 2020. bioRxiv.</a>
	</div>
</section> -->

<section>
	<h3>~23 mutations per year across SARS-CoV-2 genome</h3>
	<img class="stretch" data-src="/images/talks/ncov_mutation_rate_nuc_clock_2021_02_05.png">
</section>

<section>
	<h3>Substantial increase in spike S1 amino acid substitutions in VOCs</h3>
	<img class="stretch" data-src="/images/talks/ncov_mutation_rate_spike_clock_2021_02_05.png">
</section>

<section>
	<h3>Spike S1 rate of 2.9 subs per year similar to rate in HA1 of flu A</h3>
	<img class="stretch" data-src="/images/talks/flu_mutation_rate_ha1_clock_across_subtypes.png">
</section>

<section>
	<h3>Influenza H3N2 drifts at ~1 two-fold HI dilution per year</h3>
	<img class="stretch" data-src="/images/talks/bmds_lineages_drift_stats.png">
	<div class="citation">
		<a href="http://bedford.io/papers/bedford-flux/">Bedford et al. 2014. eLife.</a>
	</div>
</section>

<section class="left-align">
	<h3>
		SARS-CoV-2 VOCs have evolved ~10 amino acid sites in S1 in over one year.
		This is rapid even for influenza A. 501Y.V2 shows an ~8-fold drop in neutralization
		titer, equivalent to ~3 years of H3N2 evolution.
	</h3>
</section>

<!--
<section data-background="#000000">
	<h1 class="title">Continued genomic surveillance</h1>
</section>

<section>
	<h3>Substantial improvements in the both the volume and cadence of US genomic surveillance</h3>
	<img class="stretch" data-src="/images/talks/ncov_genomic_surveillance_dotplot_usa_2021_02_05.png">
</section>

<section>
	<h3>My standard metric is number of sequences available from samples collected in the past 30 days</h3>
	<img class="stretch" data-src="/images/talks/ncov_genomic_surveillance_recent_sequences_usa_2021_02_05.png">
</section>

<section>
	<h3>Substantial improvements though still behind front runners</h3>
	<img class="stretch" data-src="/images/talks/ncov_genomic_surveillance_recent_sequences_comparison_2021_02_05.png">
</section>

<section class="left-align">
	<h3>Generally, I think the process for influenza strain selection is a solid model</h3>
	<p>
	<ol>
		<li>mRNA vaccines allow faster turnarounds and may push for more regional strategies</li>
		<li>Work directly from human serological data rather than naive animals</li>
		<li>Multiple valencies possible</li>
	</ol>
	</p>
</section> -->

<section>
	<h3>Acknowledgements</h3>

	<p class="tiny">
		<b>SARS-CoV-2 genomic epi</b>: Data producers from all over the world, GISAID and the Nextstrain team
	</p>
	<p class="tiny"><b>Bedford Lab</b>:
		<span class="nobreak"><img width=35 class="img-avatar" src="/images/team/allison-black.jpg"> Alli Black,</span>
		<span class="nobreak"><img width=35 class="img-avatar" src="/images/team/john-huddleston.jpg"> John Huddleston,</span>
		<span class="nobreak"><img width=35 class="img-avatar" src="/images/team/james-hadfield.jpg"> James Hadfield,</span>
		<span class="nobreak"><img width=35 class="img-avatar" src="/images/team/katie-kistler.jpg"> Katie Kistler,</span>
		<span class="nobreak"><img width=35 class="img-avatar" src="/images/team/louise-moncla.jpg"> Louise Moncla,</span>
		<span class="nobreak"><img width=35 class="img-avatar" src="/images/team/maya-lewinsohn.jpg"> Maya Lewinsohn,</span>
		<span class="nobreak"><img width=35 class="img-avatar" src="/images/team/thomas-sibley.jpg"> Thomas Sibley,</span>
		<span class="nobreak"><img width=35 class="img-avatar" src="/images/team/jover-lee.jpg"> Jover Lee,</span>
		<span class="nobreak"><img width=35 class="img-avatar" src="/images/team/kairsten-fay.jpg"> Kairsten Fay,</span>
		<span class="nobreak"><img width=35 class="img-avatar" src="/images/team/misja-ilcisin.jpg"> Misja Ilcisin,</span>
		<span class="nobreak"><img width=35 class="img-avatar" src="/images/team/cassia-wagner.jpg"> Cassia Wagner,</span>
		<span class="nobreak"><img width=35 class="img-avatar" src="/images/team/miguel-paredes.jpg"> Miguel Paredes,</span>
		<span class="nobreak"><img width=35 class="img-avatar" src="/images/team/nicola-mueller.jpg"> Nicola Müller,</span>
		<span class="nobreak"><img width=35 class="img-avatar" src="/images/team/marlin-figgins.jpg"> Marlin Figgins,</span>
		<span class="nobreak"><img width=35 class="img-avatar" src="/images/team/eli-harkins.jpg"> Eli Harkins</span>
	</p>

	<div class="pull-right" style="vertical-align: bottom; display: table-cell;">
		<img width="11%" data-src="/images/talks/logo_fred_hutch_vertical.png">
		&nbsp; &nbsp;
		<img width="8%" data-src="/images/talks/logo_pew.png">
		&nbsp; &nbsp;
		<img width="14%" data-src="/images/talks/logo_bmgf.png">
		&nbsp; &nbsp;
		<img width="12%" data-src="/images/talks/logo_gates_ventures.png">
		&nbsp; &nbsp;
		<img width="11%" data-src="/images/talks/logo_wellcome_trust.jpg">
		&nbsp; &nbsp;
		<img width="7%" data-src="/images/talks/logo_nih.jpg">
		&nbsp; &nbsp;
		<img width="12%" data-src="/images/talks/logo_osp.jpg">
	</div>
</section>
